# What to ask when shoulder research sounds promising *What Research Can Tell You | Shoulder Regeneration Queen Creek* > Shoulder regeneration Queen Creek research made plain, with questions about who was studied and what changed. Night after night of aching can make hopeful claims sound worth trying. Yet a real study may not match your shoulder or your main concern. You don't need to sort through every chart yourself. I'd bring a few plain questions to the doctor who explains the choice. ## What to ask about the people studied First ask whether the study included people with your kind of shoulder soreness. Then ask how long their ache had lasted. Find out what they tried before joining, such as exercise or surgery. Tendon wear, marked stiffness, and arthritis aren't one problem. Age, past surgery, and the length of the ache may matter. You can ask, “How much were these people like me?” A result from a knee can't answer every shoulder question. The doctor can explain why that result does or doesn't apply. ## What to ask about the comparison A treatment may look helpful when it's compared only with waiting. Waiting isn't real care, so ask what the other group received. Ask whether the other people received exercise, medicine, or a similar office procedure. That answer tells you what the study truly tested. Small gains may not change sleep, dressing, or driving. Ask how many people felt a difference they could use. ## What to ask about time and cost Find out when people first improved and how long the change lasted. You won't want an early gain described as a lasting result. Ask whether follow-up care added more time or cost. When insurance doesn't pay, even a manageable first price can strain your budget. Keep your own goal simple and clear. If the care won't help that task, the study may not answer your question. ## Sources 1. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 2. A GRADE-rated systematic review and meta-analysis of 16 randomized trials (807 participants) found that MSC therapy for chronic knee OA pain PROBABLY RESULTS IN LITTLE TO NO DIFFERENCE in pain relief at 3-6 months (WMD -0.74 cm on a 10 cm VAS against a minimally important difference of 1.5 cm) or physical functioning (WMD 2.23 on the SF-36 100-point subscale against a 10-point MID), both moderate certainty; at 12 months pain was again probably little-to-no-different (WMD -0.73 cm). The measured effect is real but sits BELOW the threshold at which a patient would notice it. Sadeghirad B, et al. — [Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.](https://pubmed.ncbi.nlm.nih.gov/38777213/). *Osteoarthritis and cartilage*, 2024. DOI: 10.1016/j.joca.2024.04.021. 3. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit. Awad G, et al. — [Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/41863718/). *Clinical rheumatology*, 2026. DOI: 10.1007/s10067-026-08042-w. 4. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other. Eckstein F, et al. — [Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.](https://pubmed.ncbi.nlm.nih.gov/33962962/). *Annals of the rheumatic diseases*, 2021. DOI: 10.1136/annrheumdis-2020-219181. 5. A systematic review of the discordance between clinical and radiographic knee osteoarthritis: many people with severe-looking x-rays have little pain, and many with disabling pain have modest radiographic change. This is the reason a post-treatment scan is a poor proxy for how someone feels, in either direction. Bedson J, et al. — [The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature.](https://pubmed.ncbi.nlm.nih.gov/18764949/). *BMC musculoskeletal disorders*, 2008. DOI: 10.1186/1471-2474-9-116. 6. A meta-analysis of eight randomized trials of PRP for rotator cuff tendinopathy concluded PRP was a safe and effective intervention for long-term pain control and shoulder function - but the review itself records that PRP preparation and injection technique varied between studies and that the control interventions differed (saline in four trials, rehabilitation or dry needling in the other four), which is why its conclusion sits alongside more cautious reviews rather than settling the question. A Hamid MS, et al. — [Platelet-rich plasma for rotator cuff tendinopathy: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/33970936/). *PLoS One*, 2021. DOI: 10.1371/journal.pone.0251111. 7. The Cochrane review of corticosteroid injections for shoulder pain included 26 trials (median 52 participants each) and concluded there is LITTLE overall evidence to guide treatment: subacromial injection for rotator cuff disease showed a small benefit over placebo in some trials but no benefit over NSAIDs when three trials were pooled, and intra-articular injection for adhesive capsulitis showed a possible early benefit that was 'small and not well-maintained'. Buchbinder R, et al. — [Corticosteroid injections for shoulder pain.](https://pubmed.ncbi.nlm.nih.gov/12535501/). *Cochrane Database Syst Rev*, 2003. DOI: 10.1002/14651858.CD004016. 8. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA*, 2020. ## What to bring to the conversation Write down when soreness started, the task that hurts, and prior care. Pack your medicines, earlier scan reports, and questions about time and cost. Book a free consultation: --- Straight answers for a sore shoulder. Help for an aching shoulder, safe things to try, urgent signs, clinic visits, and non-surgical choices near Queen Creek. Read what the ache may mean, which home steps fit, and when an exam matters. This Queen Creek shoulder guide is operated by the owners of the QC Kinetix Phoenix-area clinics. © 2026 Queen Creek Shoulder Field Notes. Educational information only; not a substitute for individual medical advice, diagnosis or emergency care.